BlueIO

CyberSaint Security is a pioneering company focused on enhancing cyber risk assessment and management through its advanced CyberStrong platform. This platform supports the integration of security operations, continuous compliance, and risk management, catering primarily to Chief Information Security Officers (CISOs) and IT compliance teams in Fortune 500 companies. CyberStrong allows organizations to achieve real-time risk management and automate compliance assessments efficiently. By leveraging patented artificial intelligence, actuarial data, and financial modeling, it helps translate cyber risks into financial terms, providing executive-level insights that facilitate informed decision-making. Hundreds of customers utilize CyberStrong to standardize their cybersecurity frameworks, quantify risks, and improve their overall risk management posture, ultimately leading to significant cost savings. CyberSaint has garnered industry recognition, including being named a Gartner Cool Vendor and receiving several prestigious awards for its contributions to integrated risk management and cybersecurity.

Virsec is a cybersecurity company that provides protection-first software to secure applications from within the runtime. Its technology makes server workloads self-protecting by mapping allowed application execution and stopping malicious code before it can run, defending against known and unknown attacks, including zero-days. The solution monitors processes in memory to detect deviations in real time, safeguarding critical applications across environments. Virsec has been tested by government red teams and is trusted by several Fortune 100 companies. The company is headquartered in San Jose, California, with offices worldwide.

Ourly is a digital allowance platform for banks that provides tools to remove the friction that parents and kids struggle with regarding money matters. Their best-in-breed SaaS platform empowers financial institutions to “turn on” financial literacy as a youth banking solution – standalone or integrated.

CyberSaint Security is a pioneering company focused on enhancing cyber risk assessment and management through its advanced CyberStrong platform. This platform supports the integration of security operations, continuous compliance, and risk management, catering primarily to Chief Information Security Officers (CISOs) and IT compliance teams in Fortune 500 companies. CyberStrong allows organizations to achieve real-time risk management and automate compliance assessments efficiently. By leveraging patented artificial intelligence, actuarial data, and financial modeling, it helps translate cyber risks into financial terms, providing executive-level insights that facilitate informed decision-making. Hundreds of customers utilize CyberStrong to standardize their cybersecurity frameworks, quantify risks, and improve their overall risk management posture, ultimately leading to significant cost savings. CyberSaint has garnered industry recognition, including being named a Gartner Cool Vendor and receiving several prestigious awards for its contributions to integrated risk management and cybersecurity.

Virsec is a cybersecurity company that provides protection-first software to secure applications from within the runtime. Its technology makes server workloads self-protecting by mapping allowed application execution and stopping malicious code before it can run, defending against known and unknown attacks, including zero-days. The solution monitors processes in memory to detect deviations in real time, safeguarding critical applications across environments. Virsec has been tested by government red teams and is trusted by several Fortune 100 companies. The company is headquartered in San Jose, California, with offices worldwide.

Lumicell, Inc. is a company focused on developing and marketing innovative image-guided solutions for cancer surgery. It specializes in technology that provides real-time visual feedback to surgeons regarding the presence of residual cancer cells within the tumor bed. The core of Lumicell's system includes a handheld imaging device and a cancer-specific optical contrast agent that illuminates cancer cells, allowing for thorough removal of cancerous tissue during surgery. The company's lead product is currently undergoing clinical trials, particularly in breast cancer surgery, where it aims to reduce the rates of positive margins and repeat surgeries while preserving healthy tissue. Additionally, Lumicell's technology is being explored for use in other types of cancer, such as colorectal cancer and pancreatic cancer. Founded in 2008 and based in Wellesley, Massachusetts, Lumicell has demonstrated a strong safety profile for its imaging agent and has not missed any cancer detections in clinical studies to date.